Recent Blog Posts
Barriers to cancer clinical trials participation
Ongoing cancer clinical trials in Africa in 2020 From Unger J.M. et al. JNCI J Natl Cancer Inst 2019. * Circles represent individual clinical trials * Colors of the circles represent the study’s primary sponsor type The cancer clinical trials context Clinical...
Pharmalys Ltd: Our Commitment to Quality
As an international Contract Research Organisation (CRO), Pharmalys Ltd has always been dedicated to delivering excellence in every service we provide, ensuring quality at every step. Our Business Excellence and Quality Management team is integral to all our services,...
Future prospects in clinical research
Strategies for the future of clinical research: decentralised clinical trials Challenges with traditional clinical trials The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system...
Arthur Makadi, Strategic Projects Coordinator, shares his experience since joining the Pharmalys team
In April 2024, I embarked on a pivotal journey as the Strategic Projects Coordinator at Pharmalys, an organisation recognised for its commitment to advancing global health through clinical research conducted in adherence to international guidelines and high-quality...
Five reasons why we should invest in women-owned businesses
In the pursuit of inclusive economic growth, one of the most important avenues to explore is the support of women-owned businesses. Across the globe, women entrepreneurs are not just contributors to economies, they are agents of change, driving innovation, creating...
Strategies for the future of clinical research: decentralised clinical trials
Challenges with traditional clinical trials The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system interventions. They are centred around the trial site(s). The trial protocols...
Newsletter March 2024
#CountAfricaIn in the field of clinical research Pharmalys team takes the floor! Pharmalys team members give their feedback on how to improve the Pharmalys Voice concept Introduced in March 2023, Pharmalys Voice represents a recurrent team gathering designed...
The underrepresentation of racial and ethnic minority groups in randomised controlled clinical trials limits the generalisability of healthcare findings
In recent years, growing concern has been raised regarding the lack of diversity in health and clinical research trials. As an increasing number of studies investigate the underrepresentation of racial and ethnic minority groups in health research, a notable discourse...
Continuous Excellence – Soft Skills Training Programme
Excellence is Pharmalys’ creed At Pharmalys, we foster a culture of excellence. Excellence defines our mission to help advance health through data excellence; it drives our daily work, it characterises of our relationships with customers Accueil | Pharmalys. In...
Supporting and expanding the Clinical Research ecosystem in Africa is part of Pharmalys’ mission
Capacity building programme AMELIORER, in Benin The clinical research context in Africa With continued interest in advancing clinical trial conduct in sub-Saharan Africa, there is a growing imperative to strengthen pharmacovigilance systems, develop and reinforce the...